Description: Terumo Corporation develops, manufactures, and distributes medical devices and services worldwide. The company operates through three segments: Cardiac and Vascular Company, General Hospital Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stent, intravascular ultrasound systems, drug-eluting stents, imaging catheters, and others; coils and stents for treating cerebral aneurysm, aspiration catheters and clot retrievers for treating ischemic stroke, and others; oxygenators, flow diverters, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The General Hospital Company segment provides infusion pumps, syringe pumps, solution sets, syringes, I.V. solutions, pain management products, nutritious food, adhesion barriers, blood glucose monitoring systems, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, automated blood collection systems, automated blood component processing systems, pathogen reduction technology, automated centrifugal apheresis systems, cell expansion system, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan.
Home Page: www.terumo.com
2-44-1, Hatagaya
Tokyo,
151-0072
Japan
Phone:
81 3 3374 8111
Officers
| Name | Title |
|---|---|
| Mr. Toshiaki Takagi | Chairman of the Board & Group Managing Executive Officer |
| Mr. Hikaru Samejima | Representative Director, President & CEO |
| Jin Hagimoto | CFO, CIO, GM of CFO Office, Controller & Treasury Tax Dept., J-SOX Office, IT Planning Dept. & GBS |
| Shinji Omori | CTO, GM of DX Promotion Dept. R&D Division and Executive Officer |
| Ms. Miho Mizuguchi | Executive Officer, Chief Legal Officer and GM of CLO Office, Legal & Compliance Department |
| Tomoko Adachi | Chief Human Resources Officer & Group Executive Officer |
| Mr. Kazunori Hirose | Director & Group Managing Executive Officer |
| Itaru Sakaguchi | Group Managing Executive Officer |
| Toshihiko Osada | Group Senior Managing Executive Officer & Director |
| Fumihisa Hirose | Group Managing Executive Officer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 31.5457 |
|---|---|
| Trailing PE: | 38.3654 |
| Price-to-Book MRQ: | 3.4241 |
| Price-to-Sales TTM: | 0.03 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 0 |